FTC sues major pharmacy gain professionals in excess of insulin costs The company brought action against Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of lifestyle-preserving insulin medications. This approach aligns with These attempts, the ONC stated. The industry is https://kethek.com/